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Abstract The kin1 protein kinase of the ¢ssion yeast Schizo-
saccharomyces pombe is a member of the PAR-1/MARK (par-
titioning-defective 1/microtubule-associated protein/microtubule
a⁄nity-regulating kinase) family important in eukaryotic cell
polarity and cytoskeletal dynamics. We show here that kin1
plays a role in establishing the characteristic rod-shaped mor-
phology of ¢ssion yeast. Cells in which kin1 was deleted are
viable but are impaired in growth, and are rounded at one end
or both ends. They are monopolar because after mitosis they fail
to activate bipolar growth, and are delayed in cytokinesis, re-
sulting in a high proportion of septated cells often with multiple
septa. This phenotype can be partially rescued by heterologous
expression of human MARKs, which restore bipolar growth in
most cells, but do not correct the delay in cytokinesis. Using
chromosomal epitope tagging, we show that kin1p localises to
the cell ends, except during mitosis when it disappears from cell
ends. After mitosis, kin1p ¢rst reappears at the new cell end.
Overexpression of kin1 results in a loss of polarity, with par-
tially or fully rounded cells. From these results we suggest that
kin1 is required to direct the growth machinery to the cell ends.
- 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
In eukaryotic cells, microtubules (MTs) provide a dynamic
network that is critical for the segregation of chromosomes in
mitosis and for cellular morphogenesis, enabling asymmetric
cell growth and cell polarity [1^3]. In these processes, MTs
function as tracks for regulated movement and positioning of
membranous vesicles and organelles [4].
MARKs (microtubule-associated protein/microtubule a⁄n-
ity-regulating kinases) constitute a novel serine/threonine ki-
nase family in mammals that in£uence MT stability and MT-
based transport events by phosphorylating MT-associated
proteins [5,6]. Putative orthologues of the mammalian
MARKs have been described in ¢ssion yeast (kin1 [7]), Cae-
norhabditis elegans (PAR-1 (partitioning-defective 1) [8]), and
Drosophila melanogaster (dPAR-1 [9,10]). In these organisms,
the kin1/PAR-1/MARK kinases are involved in processes re-
lated to the establishment of cell polarity. The considerable
degree of sequence conservation found in the MARK/PAR-1/
KIN family of protein kinases suggests that they may act in
an essential conserved signalling pathway governing cell po-
larity. The ¢ssion yeast Schizosaccharomyces pombe is a sim-
ple model organism for the genetic study of morphogenesis
[11]. At mitosis, the cylindrical cells undergo medial ¢ssion
and enter the next cycle by unipolar growth from the ‘old’
cell end, followed by the switch to bipolar growth, when a
second growth zone is established at the newly formed cell
end. In the present study we describe the e¡ect of deletion
and overexpression of the protein kinase kin1 on the morphol-
ogy of ¢ssion yeast, the dynamic localisation of kin1 during
polar cell growth, and we demonstrate some functional or-
thology between S. pombe kin1 and mammalian MARK ki-
nases.
2. Materials and methods
2.1. Fission yeast strains and plasmids
Standard methods were used for growth, transformation, and ge-
netic manipulation of S. pombe (available at http://www.sanger.ac.uk/
PostGenomics/S_pombe/docs/nurse_lab_manual.pdf). If not men-
tioned otherwise, all cells were grown at 32‡C on YE medium with
supplements, except for cells carrying plasmids that were grown on
minimal EMM2 medium. The pREP1, pREP41, and pREP81 plas-
mids, which allow di¡erent levels of thiamine-repressed expression,
were used for kin1 overexpression and for exogenous expression of
human and rat MARK cDNAs. pREP81 contains the lowest expres-
sion version of the nmt1 promoter, pREP41 contains a medium ex-
pression version, and pREP1 contains the strongest (wild-type) ver-
sion [12]. The kin1 cDNA was subcloned into pREP1 from pDB248-
kin1 [13] using NdeI, which was introduced by polymerase chain re-
action (PCR) at the start codon, and XhoI downstream of the termi-
nation codon. Rat MARK1 and human MARK2, MARK3, and
MARK4 were subcloned into NdeI and SmaI sites of the pREP poly-
linker using NdeI and SmaI introduced by PCR [5].
2.2. Gene disruption and gene tagging
The strain vkin1: :kanMX6 leu1-32h- was a kind gift of Dr K.
Sawin (Cancer Research UK). In this strain, the kin1 gene was deleted
using homologous recombination as described in [14]. The same meth-
od was used for chromosomal tagging of the kin1þ gene at the C-ter-
minus with 13 copies of the human c-myc epitope, resulting in the
strain kin1þ : :13myc-kanMX6 leu1-32h-. We also introduced the
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c-myc epitope tag after the SPBC32C12.03C gene, a putative pa-
ralogue which we termed kin2, resulting in the strain kin2þ : :13myc-
kanMX6 leu1-32h-.
2.3. Microscopy
Live cells were stained with calco£uor at 50 Wg/ml in 2.5 mM
sodium citrate/5 mM sodium phosphate pH 6.0 containing 50% glyc-
erol and 0.3 mg/ml p-phenylenediamine. For indirect immuno£uores-
cence analysis, cells were ¢xed in culture by incubation for 20 min
with 3.7% freshly prepared formaldehyde and 0.2% glutaraldehyde
(¢nal concentrations). The formaldehyde was added 30 s prior to
the glutaraldehyde. Alternatively, cells were ¢xed by 5^20 min incu-
bation in 320‡C methanol; or by the addition of 10% trichloroacetic
acid. All washes were performed in MT-stabilising bu¡er (PEM bu¡-
er; 100 mM PIPES, 1 mM EGTA, 1 mM MgSO4 pH 6.9). Primary
antibodies were anti-tubulin [TAT-1] 1:50 dilution), anti-tip1 1:1000
dilution, and anti-myc 9E10 (Sigma), followed by Alexa 488 goat anti-
rabbit or Alexa 546 anti-mouse secondary antibodies (Molecular
Probes). Cells were mounted in 50% glycerol, 1 Wg/ml DAPI, 0.1
mg/ml paraphenylene in 0.1 M Tris pH 8 on poly-L-lysine-coated
coverslips. Immuno£uorescence images were acquired with a Axiovert
£uorescence microscope (Zeiss) equipped with a 63U oil immersion
objective, video CCD camera (Hamamatsu model C5985) connected
to an Apple Macintosh G3/400 computer.
3. Results
3.1. vkin1 cells are monopolar
Levin and Bishop reported that the disruption of the kin1þ
gene within the catalytic domain causes S. pombe cells to grow
as spheres or cones, in contrast to wild-type cells, which grow
as rods [7]. We re-evaluated the phenotype of the kin1þ dis-
ruption in the strain vkin1: :kanMX6, where the entire kin1
gene was replaced by a kanamycin resistance cassette. Fluo-
rescence micrographs of living vkin1 cells using the dye calco-
£uor to stain the cell wall show clear morphological abnor-
malities (Fig. 1). vkin1 cells exhibit a pronounced delay in
cytokinesis: Under conditions of exponential growth, approx-
imately 40% of the cells are undergoing septation, compared
to V5% in wild-type cells (Fig. 1A). This percentage is re-
tained in the stationary growth phase, where no septated cells
are observed in wild-type cells (Fig. 1B). Upon regrowth,
these septated cells do not complete cytokinesis but form cells
with two or three septa (Fig. 1C). We also visualised MTs by
immuno£uorescence microscopy and observed a high propor-
tion of cells with a post-anaphase MT array, consistent with a
delay in the completion of septation (data not shown). vkin1
cells also show a pronounced defect in cell shape; the cells
grow monopolar and, after mitosis, the new cell end fails to
activate polarised growth (new end take-o¡, NETO). As a
result, cells often become rounded, leading to a typical
rounded or ‘cone-shaped’ morphology. Finally, vkin1 cells
tend to form clumps, probably due to a change in the cell
wall that renders them sticky.
3.2. Overexpression of kin1p leads to a loss of cell polarity
To check whether overexpression of kin1p would also a¡ect
growth polarity, we constructed plasmid pREP1-kin1, which
allows the overexpression of the kin1þ gene under the control
of the strong nmt promoter. Wild-type cells were transformed
with this plasmid and released from thiamine repression. Cells
overexpressing kin1 tend to be more rounded than wild-type
cells (Fig. 2). This overexpression phenotype was not dramat-
ic, possibly due to the fact that the kin1p kinase, like mam-
malian MARKs [15], may require activation by phosphoryla-
tion by an upstream kinase to become catalytically active.
3.3. Partial rescue of the vkin1 phenotype by mammalian
MARKs
We next asked whether it is possible to rescue the kin1
Fig. 1. S. pombe cells in which the kin1 gene has been deleted show distinct morphological abnormalities. The upper panels show cells lacking
the kin1 gene (vkin1: :kanMX6) ; the lower panels show wild-type cells (972 strain) for comparison. Live cells were stained with the cell wall
dye calco£uor. Left panels (A): Cells growing exponentially at 25‡C. All vkin1 cells are monopolar and about 40% of the cells are septating,
compared to V5% in wild-type cells. Middle panels (B): Starved cells. The 40% percentage of septating cells is retained, whereas no septated
cells are observed in wild-type cells. Right panels (C): Cells regrowing after starvation. Many septated vkin1 cells do not complete cytokinesis
but form cells with two or three septa.
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deletion by the ectopic expression of mammalian MARK ki-
nases, which are candidate functional orthologues of ¢ssion
yeast kin1. The study of MARK function in cultured mam-
malian cells has been hampered by the toxicity of overex-
pressed MARK. This results in low transfection rates and
low viability of transformants [5]. In S. pombe, we attempted
to solve this problem by the use of plasmid vectors that allow
expression under the control of repressible nmt1 promoters
with di¡erent activity [12]. We found that higher levels of
MARK expression, as achieved from the full-strength nmt
promoter, are also toxic to S. pombe cells, and at ¢rst sight
it appeared that, even with the low-expression promoters
nmt41 and nmt81, no signi¢cant rescue was observed, espe-
cially because analysis of individual cells was hampered by the
tendency to form cell clumps. However, closer inspection re-
vealed that the expression of low levels of MARK1 and
MARK2 (under control of the nmt81 promoter) indeed re-
stores bipolar growth to some cells, whereas all of the vkin1
cells are de¢cient in NETO, the initiation of growth from the
new cell end (Fig. 3A^C). Under the conditions of these ex-
periments, MARK4 appeared to be even more toxic and
failed to partially rescue the NETO defect (Fig. 3D). How-
ever, even in the case of MARK1 and MARK2 the rescue of
the NETO defect was only seen in a subset of cells, and the
tendency of the cells to form clumps was not reversed.
3.4. kin1p but not kin2p localises to cell ends
In polarised cells, mammalian MARKs as well as the pu-
tative nematode and £y orthologues show distinct polar local-
isation patterns [9,10,16^20]. For example, in Madin^Darby
canine kidney cells, MARK2 localises at the tight junctions
that form the boundary between the apical and the basolateral
membrane [21], and in neuroblastoma cells, MARK4 is found
at the tip of the neuritic processes (B. Trinczek and G. Drewes,
unpublished data). Hence we asked whether kin1p adopts a
polarised localisation to a¡ect ¢ssion yeast growth polarity.
Therefore we constructed epitope-tagged S. pombe strains,
fusing kin1 at the carboxy-terminus with c-myc, haemaggluti-
nin (HA), and green £uorescent protein (GFP) tags by homol-
ogous recombination. We found that only the tag consisting
of 13 c-myc epitopes allowed detection of kin1p by indirect
immuno£uorescence. The tagged kin1 protein shows a pro-
nounced localisation to one or both cell ends (Fig. 4B). The
fusion protein is expressed at a size of 115 kDa as detected by
immunoblotting (Fig. 4A).
To analyse whether this localisation is a speci¢c feature of
kin1p and not a staining artefact, we performed myc-epitope
tagging in an analogous fashion on the closest homologue of
kin1, the putative paralogue SPBC32C12.03C, which we
termed kin2. Kin2 contains the amino-terminal catalytic do-
main but lacks the carboxyl-terminal ‘spacer’ and C-terminal
KA domains [15]. Indirect immuno£uorescence analysis re-
vealed that kin2p does not exhibit localisation to the cell
ends but shows a uniform cytoplasmic distribution (Fig. 4D).
3.5. kin1p localises to the new cell end after mitosis
From an analysis of the kin1p staining in the
kin1þ : :13myc-kanMX6 cells in di¡erent stages of growth, it
appeared that the localisation of kin1p to the cell ends is lost
in mitosis. The signal disappears from cell ends between late
anaphase and the completion of cytokinesis (Fig. 4B, cells
labelled ‘M’). Interestingly, this is the stage where vkin1 cells
fail to properly reactivate growth and get delayed or arrested
as described above. Some time after the completion of septa-
tion, kin1p reappears ¢rst at the cell end which is newly
formed after cytokinesis. The new cell end can be clearly dis-
tinguished from the ‘old’ end as it is less pointed (Fig. 4B,
cells labelled ‘N’). Later in interphase, in longer cells, kin1p is
mostly found at both cell ends (Fig. 4B, cells labelled ‘O’).
These results are summarised in the cartoon in Fig. 4C.
The disappearance of kin1p from the cell ends during mi-
tosis is not due to protein degradation, since expression levels
of kin1p are constant during mitosis, as assayed by immuno-
Fig. 2. Overexpression of kin1 a¡ects cell shape. Overexpression of
kin1 was achieved from the full-strength nmt1 promoter (pREP1)
and live cells were stained with calco£uor 4 h after release from thi-
amine repression. Cells overexpressing kin1p tend to be more
rounded than wild-type cells.
Fig. 3. Ectopic expression of mammalian MARK kinases in vkin1
cells partially restores bipolar growth. Expression of rat MARK1
(A), rat MARK2 (B), human MARK3 (C) and human MARK4
(D) in the vkin1: :kanMX6 strain. MARK genes were cloned into
pREP81 (weak nmt promoter) and transformed into S. pombe. Ex-
pression was induced by release from thiamine repression and live
cells were stained with calco£uor. Bipolar growth is restored to
some cells in panels A^C, and the percentage of cells in septation is
lower compared to non-transformed vkin1 cells. However, the ten-
dency of the vkin1 cells to form clumps is not a¡ected.
FEBS 27715 23-10-03 Cyaan Magenta Geel Zwart
G. Drewes, P. Nurse/FEBS Letters 554 (2003) 45^49 47
blotting in a cross of the kin1þ : :13myc-kanMX6 with a
cdc25ts strain that was blocked at 36‡C and subsequently
cooled, allowing progression through mitosis (data not
shown).
3.6. The cell end marker tea1 is not a¡ected in vkin1 cells
The putative orthologue of kin1 in Saccharomyces cerevisi-
ae, termed Kin1, forms a protein complex with the Kelch
repeat protein Kel1 ([26], see also http://yeast.cellzome.com/).
The likely orthologue of S. cerevisiae KEL1 in ¢ssion yeast is
tea1, which encodes a cell end marker [22,27]. It is tempting to
speculate that kin1p might function by directing the growth
machinery to the cell ends and/or regulates the dynamic pro-
cesses involving the cytoskeletal elements required for growth
Fig. 4. After mitosis kin1p localises ¢rst to the new, and later to both cell ends. A: In the chromosomally tagged cells, kin1p is expressed at a
size of 115 kDa and kin2p is expressed at a size of 55 kDa by immunoblot analysis. B: Immuno£uorescence micrographs of an epitope-tagged
kin1þ : :13myc-kanMX6 strain. Kin1 is stained in green, nuclei are stained with DAPI (blue). The localisation of kin1p to the cell ends is lost
late in mitosis, during late anaphase to cytokinesis (see cells labelled ‘M’). Kin1p appears at the cell ends somewhere between the completion
of septation and cytokinesis, but always ¢rst at the newly formed ‘edged’ cell end, which is distinguished from the rounded ‘old’ end (see cells
labelled ‘N’). Larger cells also show labelling of the old end (see cells labelled ‘O’). C: Cartoon summarising the localisation results from the
micrographs in panel B. D: Immuno£uorescence micrographs of an epitope-tagged kin2þ : :13myc-kanMX6 strain. Kin2p does not exhibit local-
isation to the cell ends but shows a cytoplasmic staining.
Fig. 5. tea1p localisation is not a¡ected in vkin1 cells. A,B: Indirect immuno£uorescence staining of vkin1: :kanMX6 (A) and wild-type
S. pombe (B) with antibodies against tubulin (red) and tea1p (green). Deletion of kin1 does not signi¢cantly a¡ect the MT array and the cell
end marker tea1p.
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at the cell end. Hence we asked whether the localisation of
tea1p [22] is a¡ected in our kin1 deletion strain. Using immu-
no£uorescence microscopy, we found that the cell end marker
tea1p retained proper localisation in most vkin1 cells (Fig.
5A).
4. Discussion
Protein kinases of the PAR-1/MARK family play crucial
roles in the establishment of cell polarity in organisms as
diverse as C. elegans [8,19], D. melanogaster [9,10,17], and
cultured mammalian cells [21,24,25]. Hence it is tempting to
speculate that these kinases are true orthologues which oper-
ate in a conserved signalling pathway controlling cell polarity.
However, the underlying molecular mechanism of the e¡ect
on cell polarity in these di¡erent organisms remains unclear,
as little is known about the upstream regulatory mechanisms
and the downstream e¡ects, e.g. the phosphorylation of sub-
strate proteins. In this study, we further characterise kin1p,
which constitutes the single member of this protein kinase
family in ¢ssion yeast. We show that both the loss and over-
expression of kin1p interfere with proper cell morphogenesis,
and that the localisation of kin1p is not speci¢cally restricted
during cytokinesis, but soon afterwards it is redistributed to
the newly formed cell end and later in interphase it is found at
both cell ends. This is consistent with a scenario where kin1p
has a function in directing the growth machinery towards the
new cell end, and in the absence of kin1 cells grows only from
the old end and remains monopolar. However, it seems that
kin1p has an additional function in cytokinesis but not in
septation directly, since vkin1 cells are delayed post-anaphase,
leading to the accumulation of multi-septated cells.
The Drosophila and mammalian members of the PAR-1/
MARK kinase family play a role in MT organisation [5,17].
We show that, in ¢ssion yeast, the deletion of kin1 has no
dramatic e¡ect on MTs, other than many cells displaying a
post-anaphase array as a result of the delayed cytokinesis. The
cell cycle-dependent recruitment of kin1p to the cell ends sug-
gests that it may bind in a regulated fashion to an end-marker
protein. As described above, kin1p and the end marker tea1p
are interlogues; their possible orthologues in budding yeast
interact in a protein complex. The positioning of polarised
growth sites at the opposite ends of the ¢ssion yeast cell de-
pends on the delivery of tea1p to the cell end [22]. We show
that the localisation of tea1p is largely preserved in vkin1
cells, which suggests that tea1p functions upstream of kin1p.
Another protein dependent on tea1p is the MT end-associated
protein tip1p, which is less abundant at the cell ends in tea1-
deleted cells [23]. Interestingly, it was recently reported that,
in Drosophila, loss of PAR-1 disrupts the asymmetric local-
isation of the MT plus ends, which are mislocalised to the
centre of mutant cells, and it was suggested that dPAR-1
functions by regulating MT plus ends by capping them at
the basal cortex [28].
The fact that tea1 does not have an orthologue in mam-
mals, and that ectopic expression of the mammalian MARKs
was only partially able to rescue the vkin1 phenotype, sug-
gests that despite the high conservation in the kin1/PAR-1/
MARK family, the actual molecular mechanisms have di-
verted during evolution.
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